Protective effects of GLP-1 analogues exendin-4 and GLP-1 (9–36) amide against ischemia–reperfusion injury in rat heart DP Sonne, T Engstrøm, M Treiman Regulatory peptides 146 (1-3), 243-249, 2008 | 366 | 2008 |
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus B Hemmingsen, JB Schroll, SS Lund, J Wetterslev, C Gluud, A Vaag, ... Cochrane Database of Systematic Reviews, 2013 | 142 | 2013 |
Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential … B Hemmingsen, JB Schroll, J Wetterslev, C Gluud, A Vaag, DP Sonne, ... Canadian Medical Association Open Access Journal 2 (3), E162-E175, 2014 | 139 | 2014 |
Response to Comment on American Diabetes Association. Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1):S1–S135 WH Herman, M Petersen, RR Kalyani Diabetes care 40 (7), e94-e95, 2017 | 133 | 2017 |
Clinical relevance of the bile acid receptor TGR5 in metabolism FS van Nierop, MJ Scheltema, HM Eggink, TW Pols, DP Sonne, FK Knop, ... The lancet Diabetes & endocrinology 5 (3), 224-233, 2017 | 133 | 2017 |
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes E Bahne, EWL Sun, RL Young, M Hansen, DP Sonne, JS Hansen, ... JCI insight 3 (23), 2018 | 121 | 2018 |
Postprandial plasma concentrations of individual bile acids and FGF-19 in patients with type 2 diabetes DP Sonne, FS van Nierop, W Kulik, MR Soeters, T Vilsbøll, FK Knop The Journal of Clinical Endocrinology & Metabolism 101 (8), 3002-3009, 2016 | 120 | 2016 |
Mechanisms in endocrinology: bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion DP Sonne, M Hansen, FK Knop European journal of endocrinology 171 (2), R47-R65, 2014 | 96 | 2014 |
Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon‐like peptide‐1 secretion M Hansen, MJ Scheltema, DP Sonne, JS Hansen, M Sperling, JF Rehfeld, ... Diabetes, Obesity and Metabolism 18 (6), 571-580, 2016 | 88 | 2016 |
Bile acid sequestrants for glycemic control in patients with type 2 diabetes: a systematic review with meta-analysis of randomized controlled trials M Hansen, DP Sonne, KH Mikkelsen, LL Gluud, T Vilsbøll, FK Knop Journal of Diabetes and its Complications 31 (5), 918-927, 2017 | 79 | 2017 |
Involvement of glucagon‐like peptide‐1 in the glucose‐lowering effect of metformin E Bahne, M Hansen, A Brønden, DP Sonne, T Vilsbøll, FK Knop Diabetes, Obesity and Metabolism 18 (10), 955-961, 2016 | 75 | 2016 |
Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes M Hansen, DP Sonne, FK Knop Current diabetes reports 14, 1-9, 2014 | 71 | 2014 |
Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in … B Hemmingsen, DP Sonne, MI Metzendorf, B Richter Cochrane Database of Systematic Reviews, 2017 | 64 | 2017 |
Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1 DP Sonne, JF Rehfeld, JJ Holst, T Vilsbøll, FK Knop European Journal of Endocrinology 171 (4), 407-419, 2014 | 64 | 2014 |
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients DP Sonne, KJ Hare, P Martens, JF Rehfeld, JJ Holst, T Vilsbøll, FK Knop American Journal of Physiology-Gastrointestinal and Liver Physiology 304 (4 …, 2013 | 64 | 2013 |
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19 V Backer, U Sjöbring, J Sonne, A Weiss, M Hostrup, HK Johansen, ... The Lancet Regional Health–Europe 4, 2021 | 59 | 2021 |
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes … B Hemmingsen, DP Sonne, MI Metzendorf, B Richter Cochrane Database of Systematic Reviews, 2016 | 44 | 2016 |
Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity CC Nexøe‐Larsen, PH Sørensen, H Hausner, M Agersnap, M Baekdal, ... Diabetes, Obesity and Metabolism 20 (11), 2557-2564, 2018 | 40 | 2018 |
Cholecystokinin-induced gallbladder emptying and metformin elicit additive glucagon-like peptide-1 responses U Rohde, DP Sonne, M Christensen, M Hansen, A Brønden, S Toräng, ... The Journal of Clinical Endocrinology & Metabolism 101 (5), 2076-2083, 2016 | 30 | 2016 |
Glucose‐lowering effects and mechanisms of the bile acid‐sequestering resin sevelamer A Brønden, K Mikkelsen, DP Sonne, M Hansen, C Våben, MN Gabe, ... Diabetes, Obesity and Metabolism 20 (7), 1623-1631, 2018 | 26 | 2018 |